• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅觉丧失作为帕金森病诊断的支持特征:一种实用方法。

Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.

机构信息

Lincoln County Hospital, Lincoln, LN2 5QY, UK.

出版信息

J Neurol. 2013 Dec;260(12):2951-8. doi: 10.1007/s00415-013-6848-8. Epub 2013 Feb 3.

DOI:10.1007/s00415-013-6848-8
PMID:23377435
Abstract

There is ample evidence from a large number of clinical and pathological studies of an early involvement of olfactory bulbs and cortex in the Lewy body pathology in idiopathic Parkinson's disease (iPD), the olfactory system being one of the first targets of degeneration in this condition. The olfactory dysfunction may be measurably present at the time of initial presentation and progresses in a proportion of patients as the disease advances. Patients with iPD have a more severe olfactory loss as compared to multisystem atrophy whereas the syndromes of corticobasal degeneration and progressive supranuclear palsy have no olfactory loss. A proportion of drug induced parkinsonism may have olfactory loss indicative of primary pathology of dopaminergic degeneration in these patients. Unlike single photon emission tomography, formal measurement of olfaction would provide a supportive role in diagnosing or excluding iPD depending on the duration of an individual patient's parkinsonian symptoms. Whilst olfaction may be only minimally impaired in early stages and may thus not help to differentiate from other syndromes, an intact olfaction in patients with parkinsonism of few years' duration would indicate a non-iPD pathology. Olfactory measurement is easy, cheap and now easily available in a number of tests, and olfactory assessment at different stages of parkinsonism should be used as a diagnostic aid for idiopathic PD and would enhance the diagnostic accuracy of iPD when used in conjunction with the UK Parkinson's disease society Brain Bank supportive criteria for diagnosis of idiopathic Parkinson's disease.

摘要

大量的临床和病理学研究充分表明,在特发性帕金森病(iPD)中,嗅球和皮质很早就涉及路易体病理学,嗅觉系统是这种疾病最早发生退行性变的靶器官之一。嗅觉功能障碍在疾病初始发作时可能已经可以测量到,并在疾病进展过程中在一部分患者中逐渐加重。与多系统萎缩相比,iPD 患者的嗅觉丧失更为严重,而皮质基底节变性和进行性核上性麻痹综合征则没有嗅觉丧失。一部分药物诱导的帕金森病可能存在嗅觉丧失,表明这些患者存在多巴胺能退行性变的原发性病理。与单光子发射计算机断层扫描不同,嗅觉的正式测量将根据个体帕金森病症状的持续时间,为诊断或排除 iPD 提供辅助作用。尽管嗅觉在早期阶段可能只有轻微受损,因此无法帮助与其他综合征区分,但几年病程的帕金森病患者嗅觉正常,则表明存在非 iPD 病理。嗅觉测量简单、廉价,现在有多种测试方法都可以进行,在帕金森病的不同阶段进行嗅觉评估应作为 iPD 的诊断辅助手段,与英国帕金森病学会脑库支持的 iPD 诊断标准一起使用时,将提高 iPD 的诊断准确性。

相似文献

1
Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.嗅觉丧失作为帕金森病诊断的支持特征:一种实用方法。
J Neurol. 2013 Dec;260(12):2951-8. doi: 10.1007/s00415-013-6848-8. Epub 2013 Feb 3.
2
[Olfactory dysfunction in Parkinson's disease: its role as a new cardinal sign in early and differential diagnosis].[帕金森病中的嗅觉功能障碍:其在早期及鉴别诊断中作为一项新主要体征的作用]
Nervenarzt. 2008 Feb;79(2):175-84. doi: 10.1007/s00115-007-2326-9.
3
A clinical approach towards smell loss in Parkinson's disease.帕金森病嗅觉丧失的临床处理方法。
J Parkinsons Dis. 2014;4(2):189-95. doi: 10.3233/JPD-130278.
4
Olfactory function in atypical parkinsonian syndromes.非典型帕金森综合征中的嗅觉功能。
Acta Neurol Scand. 1995 Apr;91(4):247-50. doi: 10.1111/j.1600-0404.1995.tb06998.x.
5
Olfactory function in Parkinsonian syndromes.帕金森综合征中的嗅觉功能。
J Clin Neurosci. 2002 Sep;9(5):521-4. doi: 10.1054/jocn.2001.1071.
6
Olfactory function in idiopathic Parkinson's disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients.特发性帕金森病(IPD)中的嗅觉功能:IPD患者横断面研究及初发IPD患者长期随访结果
J Neural Transm (Vienna). 2002 May;109(5-6):805-11. doi: 10.1007/s007020200067.
7
EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.EFNS/MDS-ES/ENS [更正] 帕金森病诊断建议。
Eur J Neurol. 2013 Jan;20(1):16-34. doi: 10.1111/ene.12022.
8
Olfaction and Parkinson's syndromes: its role in differential diagnosis.嗅觉与帕金森综合征:其在鉴别诊断中的作用。
Curr Opin Neurol. 2004 Aug;17(4):417-23. doi: 10.1097/01.wco.0000137531.76491.c2.
9
Olfaction in neurodegenerative disorder.神经退行性疾病中的嗅觉
Adv Otorhinolaryngol. 2006;63:133-151. doi: 10.1159/000093759.
10
Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders?嗅出帕金森病:嗅觉测试能否区分帕金森氏症?
Neurologist. 2007 Nov;13(6):382-5. doi: 10.1097/NRL.0b013e31815a351a.

引用本文的文献

1
Clinical features and neurobiochemical mechanisms of olfactory dysfunction in patients with Parkinson disease.帕金森病患者嗅觉功能障碍的临床特征和神经生化机制。
J Neurol. 2024 Apr;271(4):1959-1972. doi: 10.1007/s00415-023-12122-1. Epub 2023 Dec 27.
2
Comparative Olfactory Profiles in Parkinson's Disease and Drug-Induced Parkinsonism.帕金森病与药物性帕金森综合征的嗅觉特征比较
J Mov Disord. 2024 Jan;17(1):64-70. doi: 10.14802/jmd.23105. Epub 2023 Oct 6.
3
Applicability of Sniffin' Sticks Identification Test as a Screening Tool for Olfactory Dysfunction in Northeast China.

本文引用的文献

1
Olfaction, dyskinesia and profile of weight change in Parkinson's disease: identifying neurodegenerative phenotypes.帕金森病的嗅觉、运动障碍和体重变化特征:识别神经退行性表型。
Parkinsonism Relat Disord. 2012 Sep;18(8):964-70. doi: 10.1016/j.parkreldis.2012.05.004. Epub 2012 Jun 8.
2
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.帕金森病高危综合征研究中的嗅觉障碍和其他前驱特征。
Mov Disord. 2012 Mar;27(3):406-12. doi: 10.1002/mds.24892. Epub 2012 Jan 11.
3
Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience.
《嗅探棒嗅觉识别测试在东北地区嗅觉功能障碍筛查中的应用》
Med Sci Monit. 2023 Jan 14;29:e938903. doi: 10.12659/MSM.938903.
4
Association of Odor Identification Ability With Amyloid-β and Tau Burden: A Systematic Review and Meta-Analysis.嗅觉识别能力与β-淀粉样蛋白和tau蛋白负荷的关联:一项系统评价和荟萃分析。
Front Neurosci. 2020 Nov 26;14:586330. doi: 10.3389/fnins.2020.586330. eCollection 2020.
5
Recent Advances in Biomarkers for Parkinson's Disease.帕金森病生物标志物的最新进展
Front Aging Neurosci. 2018 Oct 11;10:305. doi: 10.3389/fnagi.2018.00305. eCollection 2018.
6
Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies.阿尔茨海默病进展过程中人类嗅球转录组的渐进性调控:对跨蛋白病嗅觉信号传导的新见解
Oncotarget. 2017 May 23;8(41):69663-69679. doi: 10.18632/oncotarget.18193. eCollection 2017 Sep 19.
7
Clinical Significance of REM Sleep Behavior Disorders and Other Non-motor Symptoms of Parkinsonism.快速眼动睡眠行为障碍及其他帕金森病非运动症状的临床意义。
Neurosci Bull. 2017 Oct;33(5):576-584. doi: 10.1007/s12264-017-0164-8. Epub 2017 Aug 3.
8
Molecular Mechanism of Adult Neurogenesis and its Association with Human Brain Diseases.成人神经发生的分子机制及其与人类脑部疾病的关联
J Cent Nerv Syst Dis. 2016 Jun 20;8:5-11. doi: 10.4137/JCNSD.S32204. eCollection 2016.
9
Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.散发性阿尔茨海默病进展过程中嗅球蛋白质组动力学:跨阿尔茨海默病相关共病的常见和独特嗅觉靶点的鉴定
Oncotarget. 2015 Nov 24;6(37):39437-56. doi: 10.18632/oncotarget.6254.
10
The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.多巴胺转运体成像和嗅觉测试在帕金森综合征患者中的诊断价值。
J Neurol. 2015 Sep;262(9):2154-63. doi: 10.1007/s00415-015-7830-4. Epub 2015 Jun 30.
帕金森病的运动前期特征:檀香山-亚洲老龄化研究的经验。
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S199-202. doi: 10.1016/S1353-8020(11)70062-1.
4
Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.帕金森病嗅觉功能障碍的运动和非运动相关性。
J Neurol Sci. 2011 Nov 15;310(1-2):21-4. doi: 10.1016/j.jns.2011.06.020. Epub 2011 Jun 25.
5
Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease.嗅觉功能障碍与帕金森病的神经精神表现有关。
Mov Disord. 2011 Sep;26(11):2051-7. doi: 10.1002/mds.23792. Epub 2011 May 24.
6
Parkinson's disease risk score: moving to a premotor diagnosis.帕金森病风险评分:迈向运动前期诊断。
J Neurol. 2011 May;258(Suppl 2):S311-5. doi: 10.1007/s00415-011-5952-x.
7
Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.神经退行性疾病患者嗅球中多巴胺能细胞和蛋白聚集物增加。
Acta Neuropathol. 2011 Jul;122(1):61-74. doi: 10.1007/s00401-011-0830-2. Epub 2011 May 8.
8
Association of olfactory bulb volume and olfactory sulcus depth with olfactory function in patients with Parkinson disease.嗅球体积和嗅沟深度与帕金森病患者嗅觉功能的关系。
AJNR Am J Neuroradiol. 2011 Apr;32(4):677-81. doi: 10.3174/ajnr.A2350. Epub 2011 Feb 17.
9
Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease.早期帕金森病的弥散张量成像和嗅觉识别测试。
J Neurol. 2011 Jul;258(7):1254-60. doi: 10.1007/s00415-011-5915-2. Epub 2011 Feb 3.
10
Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease.帕金森病患者嗅觉功能障碍与大脑代谢的相关性研究。
Mov Disord. 2011 Mar;26(4):621-8. doi: 10.1002/mds.23602. Epub 2011 Jan 31.